Abstract
Chronic sleep difficulties commonly coexist with neurodevelopmental and psychiatric problems. Children with special needs may have a variety of sleep disturbances and of these circadian rhythm sleep disorders appear to be the most common. Melatonin supplementation for some circadian rhythm sleep disorders is often an effective treatment because it corrects the associated abnormal melatonin secretion. Melatonin has a benign safety profile and significant potential health benefits. Melatonin has many functions including sleep promoting and chronobiotic properties. Melatonin therapy is only beneficial when persistent sleep difficulties are associated with low melatonin secretion and additional supplementation beyond the therapeutic dose does not result in further sleep promotion. Abnormal neurological modulation of pineal melatonin secretion is commonly present in neurodevelopmental and psychiatric disorders. Melatonin deficiency not only leads to sleep disturbance, but also to multiple health problems. Chronic sleep difficulties of special needs children must not be ignored because they may exacerbate the deficits in development which are already present. In this review, misconceptions about sleep and melatonin therapy, functions of this indoleamine, causes and diagnoses of circadian rhythm sleep disorders, physiological principles underlying treatment, selection of candidates, dose, safety and health benefits are discussed.
Keywords: Children, melatonin, sleep disorder, therapy, disabilities
Current Pediatric Reviews
Title: Melatonin Therapy of Pediatric Sleep Disorders: Recent Advances, Why it Works, Who are the Candidates and How to Treat
Volume: 3 Issue: 3
Author(s): James E. Jan, Michael B. Wasdell, Russel J. Reiter, Margaret D. Weiss, Kyle P. Johnson, Anna Ivanenko and Roger D. Freeman
Affiliation:
Keywords: Children, melatonin, sleep disorder, therapy, disabilities
Abstract: Chronic sleep difficulties commonly coexist with neurodevelopmental and psychiatric problems. Children with special needs may have a variety of sleep disturbances and of these circadian rhythm sleep disorders appear to be the most common. Melatonin supplementation for some circadian rhythm sleep disorders is often an effective treatment because it corrects the associated abnormal melatonin secretion. Melatonin has a benign safety profile and significant potential health benefits. Melatonin has many functions including sleep promoting and chronobiotic properties. Melatonin therapy is only beneficial when persistent sleep difficulties are associated with low melatonin secretion and additional supplementation beyond the therapeutic dose does not result in further sleep promotion. Abnormal neurological modulation of pineal melatonin secretion is commonly present in neurodevelopmental and psychiatric disorders. Melatonin deficiency not only leads to sleep disturbance, but also to multiple health problems. Chronic sleep difficulties of special needs children must not be ignored because they may exacerbate the deficits in development which are already present. In this review, misconceptions about sleep and melatonin therapy, functions of this indoleamine, causes and diagnoses of circadian rhythm sleep disorders, physiological principles underlying treatment, selection of candidates, dose, safety and health benefits are discussed.
Export Options
About this article
Cite this article as:
James E. Jan , Michael B. Wasdell , Russel J. Reiter , Margaret D. Weiss , Kyle P. Johnson , Anna Ivanenko and Roger D. Freeman , Melatonin Therapy of Pediatric Sleep Disorders: Recent Advances, Why it Works, Who are the Candidates and How to Treat, Current Pediatric Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339607781369546
DOI https://dx.doi.org/10.2174/157339607781369546 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
AZT: An Old Drug with New Perspectives
Current Clinical Pharmacology Therapeutic Antibodies in HIV Treatment - Classical Approaches to Novel Advances
Current Pharmaceutical Design Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures
Current Drug Metabolism Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels
Current Neuropharmacology Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation
Current Neuropharmacology From Gene to Epigene-Based Therapies Targeting the Vascular Endothelium
Current Vascular Pharmacology Cerebrospinal Fluid Proteins in the Diagnosis of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Predicting Inhibitors for Multidrug Resistance Associated Protein-2 Transporter by Machine Learning Approach
Combinatorial Chemistry & High Throughput Screening Recent Patents in the Field of Radioprotector Development: Opportunities and Challenges
Recent Patents on Biotechnology Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
MicroRNA Adamantane – A Lead Structure for Drugs in Clinical Practice
Current Medicinal Chemistry Development of Novel Lyophilized Mixed Micelle Amphotericin B Formulation for Treatment of Systemic Fungal Infection
Current Drug Delivery Challenges and Advances in Infection Control of Hematopoietic Stem Cell Transplant Recipients
Infectious Disorders - Drug Targets Combination Antifungal Therapy for Invasive Aspergillosis: Utilizing New Targeting Strategies
Current Drug Targets - Infectious Disorders Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Inflammation, Hyperinflammation & Cystic Fibrosis Lung Disease – A Paradigm Shift?
Current Respiratory Medicine Reviews Inflammaging of Female Reproductive System: A Molecular Landscape
Current Aging Science The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Current Clinical Pharmacology Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)
Current Pharmaceutical Design Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design